CTHRC1 and cancer: Therefore, this is the first study that reported the shared clinicopathological features-specific diagnostic and prognostic potential of CTHRC1 in six different cancers including HNSC, KIRC, LIHC, LUAD, STAD, and UCEC, which may provide new therapeutic possibilities for cancer patients.